Neogen develops and markets diagnostic test kits to detect foodborne bacteria, drug residues, mycotoxins, food allergens and genetic modifications.Read more
NEOGEN's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 7.8B. Over the last four quarters, NEOGEN's revenue has grown by 11.8%. Specifically, in Q4 2021's revenue was $130.5M; in Q3 2021, it was $128.3M; in Q2 2021, it was $127.4M; in Q1 2021, NEOGEN's revenue was $116.7M.